← Back to Patent Explorer
US4916209A Expired / Lapsed US ⏱️ 0.0 years remaining

Bioabsorbable polydepsipeptide, preparation and use thereof

Assignee: Pfizer Inc
•
Filing: 1987-12-23
•
Granted: 1990-04-10
•
Expires: 2007-12-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel, semi-crystalline depsipeptide polymers and copolymers particularly suitable for use in fabricating bioabsorbable medical implant devices such as sutures or clips and obtained through ring-opening polymerization of certain 3-substituted-2,5-morpholinediones prepared by reacting a naturally occurring alpha-amino acid with an alpha-halo acid chloride in inert solvent in the presence of an acid acceptor.

Inventors

  • 👤 Fu-Ning Fung
  • 👤 Raymond C. Glowaky

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 12:11
CPC Classifications
C; C07; C07D; C07D265/00; C07D265/28; C07D265/30; C07D265/32; A; A61; A61L; A61L17/00; A61L17/06; A61L17/10; A61L17/12; A61L27/00; A61L27/14; A61L27/18; A61L31/00; A61L31/04; A61L31/043; A61L31/047; A61L31/06; A61L31/14; A61L31/148

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 146 words
An optically-active, hydrolyzable, semi-crystalline polydepsipeptide having a number average molecular weight of from about 5,000 to 200,000 and the structural formula V: ##STR23## wherein R is C 1 -C 12 alkyl, C 1-C 6 alkoxy (C 1 -C 6 alkyl), aryl, aryl(C 1 -C 12 alkyl), C 1 -C 12 alkylaryl, C 1 -C 6 alkylaryl(C 1 -C 6 alkyl), C 1 -C 6 alkylthio(C 1 -C 6 alkyl), C 1 -C 6 alkylsulfinyl(C 1 -C 6 alkyl), C 1 -C 6 alkylsulfonyl(C 1 -C 6 alkyl), cyano(C 1 -C 12 alkyl) or aminocarbonyl(C 1 -C 12 alkyl), with each aryl group having up to 10 carbons in the nuclear ring, p1 x,y are relative amounts of (D) and (L) optical isomers, respectively, wherein the asterisk indicates the stated optical activity, and the ratio x/(x+y) is either less than about 0.45 or greater than about 0.55.
Claim 2
Dependent Claim 146 words
An optically-active, hydrolyzable, semi-crystalline polydepsipeptide having a number average molecular weight of from about 5,000 to 200,000 and the structural formula V: ##STR23## wherein R is C 1 -C 12 alkyl, C 1-C 6 alkoxy (C 1 -C 6 alkyl), aryl, aryl(C 1 -C 12 alkyl), C 1 -C 12 alkylaryl, C 1 -C 6 alkylaryl(C 1 -C 6 alkyl), C 1 -C 6 alkylthio(C 1 -C 6 alkyl), C 1 -C 6 alkylsulfinyl(C 1 -C 6 alkyl), C 1 -C 6 alkylsulfonyl(C 1 -C 6 alkyl), cyano(C 1 -C 12 alkyl) or aminocarbonyl(C 1 -C 12 alkyl), with each aryl group having up to 10 carbons in the nuclear ring, p1 x,y are relative amounts of (D) and (L) optical isomers, respectively, wherein the asterisk indicates the stated optical activity, and the ratio x/(x+y) is either less than about 0.45 or greater than about 0.55.
Claim 3
Dependent Claim 18 words
The polydepsipeptide of claim 1 wherein R is alkyl of from 1 to 4 carbons, benzyl or 2-methylthioethyl.
Claim 4
Dependent Claim 33 words
The polydepsipeptide of claim 2 wherein the molecular weight is from about 10,000 to 50,000, R is CH 3 and x/(x+y) is from about 0.2 to 0.4 or from about 0.6 to 0.8.
Claim 5
Dependent Claim 11 words
A bioabsorbable surgical device fabricated from the polydepsipeptide of claim 1.
Claim 6
Dependent Claim 14 words
The surgical device of claim 4 in the form of a suture or clip.
Claim 7
Dependent Claim 43 words
A process for the preparation of an optically-active, hydrolyzable, semi-crystalline polydepsipeptide according to claim 1, which comprises polymerizing an optically active 3-substituted-2,5-morpholinedione having the structural formula I ##STR24## wherein R is as defined in claim 4, in the presence of an organometallic catalyst.
Claim 8
Dependent Claim 21 words
The process of claim 6 wherein the polymerization is conducted neat at a temperature of from about 100° to 250° C.
Claim 9
Dependent Claim 13 words
A process according to claim 6, wherein the organometallic catalyst is stannous octoate.

References Cited (Backward Citations)

US30170A Cited
US3773737A Cited
USRE30170E Cited
US4052988A Cited
US4209607A Cited
US4343931A Cited
US4441496A Cited
US4653497A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-04-09 1993-10-09 1994-04-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-04-09 1997-10-09 1998-04-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-04-09 2001-10-09 2002-04-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag